Big Pharma's Key Lifecycle Management Strategies
Maximizing The Market Potential
| Feb 2010 |
£2,195 |
The Healthcare CEO Perspective on Growth
| Dec 2009 |
£6,270 |
Developing Managed Care Pull-Through Excellence
| Oct 2009 |
£3,260 |
Collaboration Cubed: Industry, Government, and Academia Working Together to Improve Health
| Oct 2009 |
£940 |
Managed Markets Account Management
Assessing the Performance of Account Executives
| Oct 2009 |
£2,640 |
Collaborating with Patient Advocacy Groups to Educate the Marketplace
| Oct 2009 |
£4,075 |
The European Healthcare Asset Management Systems Market
| Sep 2009 |
£4,075 |
Best Practices: Eight Minutes to Change Their Lives
| Sep 2009 |
£2,820 |
Best Practices for Post-Marketing Surveillance of Adverse Events within the U.S.
| Sep 2009 |
£1,815 |
Leading Pharmaceutical Companies Collaborative Arrangements
| Sep 2009 |
£940 |
Leading Pharmaceutical Companies Business Organizations and Senior Management Profiles
| Sep 2009 |
£940 |
Leading Pharmaceutical Companies Comparative Analysis
| Sep 2009 |
£280 |
Technology Selection: Decision Criteria for PLM Applications to Support Sustainable Manufacturing
| Aug 2009 |
£2,820 |
Best Practices in Utilizing Health Outcomes Data for Promotional/Commercial Efforts
| Jul 2009 |
£2,195 |
Best Practices for Internal Communications Regarding Brands & Disease States
| Jul 2009 |
£4,640 |
Serving the Healthcare Needs of Employers
Employer Market Strategies and Tactics
| Jul 2009 |
£2,130 |
Best Practices in Recruitment for Medical Education Programs
| Jul 2009 |
£2,445 |
Innovations in Patient-Focused Initiatives
Case Studies in Reaching, Engaging and Supporting Patients
| Jul 2009 |
£2,870 |
Integration Strategies in the Fragmented Healthcare IT Market in Europe
| Jun 2009 |
£3,765 |
Clinical Outsourcing Strategy
Selecting Partners and Managing Relationships
| May 2009 |
£4,710 |
Thought-Leader Fair Market Value:
Compensation Benchmarks and Procedures
| Feb 2009 |
£4,710 |
Evolving Medical Information Call Centers through Performance Measurement and Process Improvement
| Jan 2009 |
£3,670 |
2009 Trendology: U.S. Medical Equipment Manufacturing
| Jan 2009 |
£250 |
Commercial Insight: Community Antibacterials - Pipelines wither as generic tidal wave takes its toll
| Jan 2009 |
£8,300 |
Finding a Place for Real Time Location Systems in Healthcare (Strategic Focus)
| Dec 2008 |
£1,190 |
Commercial Insight: Rheumatoid arthritis - Anti-TNFs defend first-line biologic position despite competition
| Dec 2008 |
£8,300 |
Virtual Pharma
The Radical Route To Success
| Sep 2008 |
£795 |
Strategic Management of Resources and Portfolios
Structuring Risk to Maximize Opportunity in Pharmaceutical R&D
| Aug 2008 |
£2,350 |
Contract Pharma 2008-2023
| Aug 2008 |
£1,499 |
Pharmaceutical Competitive Intelligence
Expanding The Role and Reach of Ci
| Jul 2008 |
£4,710 |
The Changing Msl Role
Proving Value through Performance Measurement
| Jul 2008 |
£4,710 |
Compound Management Trends 2008
| Jul 2008 |
£1,540 |
Business Development: Accelerating the Deal
| May 2008 |
£4,710 |
Educating The Market
Creating Value through Support of Continuing Medical Education
| Mar 2008 |
£3,760 |
Maintaining a Competitive Edge in Pharmaceutical Public Affairs
Benchmarking The Resources Required to Serve The U.S. Market
| Feb 2008 |
£3,640 |
Evaluation of Current Service Capabilities of Chinese Pharmaceutical Outsourcing Service Industry
| Jan 2008 |
£550 |
Guide to Pharmaceutical Outsourcing in China
| Jan 2008 |
£615 |
Anti-Counterfeiting Strategies
Combating Fake Pharmaceuticals
| Dec 2007 |
£2,380 |
Central and Core Laboratories
| Oct 2007 |
£995 |
Business Intelligence Investment In Healthcare H2 2006 (Databook)
| Sep 2007 |
£720 |
Prescribing Pharmacists
A Decision Maker Emerges
| Sep 2007 |
£1,570 |
Streamlining Information in the Pharmaceutical Industry with Product Lifecycle Management Solutions (Executive Presentation)
| Aug 2007 |
£1,190 |
Managing Process Complexity in the Pharmaceutical Industry with PLM (Strategy Focus)
| Aug 2007 |
£1,190 |
Streamlining Information in the Pharmaceutical Industry with PLM (Review Report)
| Aug 2007 |
£2,130 |
Pharmaceutical Product Lifecycle Management Forecast in North America 2006-2012 (Databook)
| Jul 2007 |
£720 |
Pharmaceutical Product Lifecycle Management Forecast in Western Europe 2006-2012 (Databook)
| Jul 2007 |
£720 |
From Idea to Market: Product Lifecycle Management in the Pharmaceutical Industry (Market Focus)
| Jul 2007 |
£1,190 |
Optimizing PLM Technology for the Pharmaceutical Industry (Technology Focus)
| Jul 2007 |
£1,190 |
Pharmaceutical Product Lifecycle Management Forecast in APAC 2006-2012 (Databook)
| Jul 2007 |
£720 |
Global Pharmaceutical Product Lifecycle Management Forecast 2006-2012 (Interactive Model)
| Jul 2007 |
£9,410 |
Evaluating Business Intelligence Opportunities in the Pharmaceutical Industry (Strategy Focus)
| Jun 2007 |
£1,190 |
Pharmaceutical Outsourcing in Drug Discovery and Development
Contract Research Opportunity in India
| Apr 2007 |
£735 |
Scientific Publications Strategy: Managing Reputation, Clinical Trial Results and Commercial Relevance (Slide Format)
| Apr 2007 |
£2,315 |
Winning Product Launch Strategies
Maximizing sales from new pharmaceutical products
| Apr 2007 |
£1,200 |
Giving the Grassroots their say
An analysis of various processes worldwide for consulting patients and the public
| Feb 2007 |
£400 |
The funding of health campaigners
| Jan 2007 |
£400 |
Outsourcing Chemistry Services Made Easy
A Guide for the Pharmaceutical and Biotech Industries
| Jan 2007 |
£695 |
Clinical Trial Supply
| Jan 2007 |
£595 |
Pharmaceutical Regulatory Affairs in the EU and US
| Dec 2006 |
£1,095 |
Pricing and Reimbursement in Japan
Costly healthcare system inefficiencies increase the focus on healthcare cost containment
| Nov 2006 |
£2,380 |
Pricing & Reimbursement in Europe
Can the drive for cost effectiveness overcome cost containment?
| Oct 2006 |
£7,150 |
Biologic drugs to drive pharmaceutical market growth
| Oct 2006 |
£1,065 |
Mergers, acquisitions and licensing to continue drive industry growth
| Oct 2006 |
£1,065 |
Reformulation Strategies
Comparisons of Past and Future Reformulation Strategies
| Sep 2006 |
£4,765 |
Biosimilars
Evolution or Revolution
| Sep 2006 |
£1,950 |
Pharmaceutical Outsourcing Opportunities Post Launch
Contract Manufacturing, and Sales and Marketing,2nd Edition
| Sep 2006 |
£2,445 |
Pharmaceutical Co-Promotion Management
| Mar 2006 |
£2,690 |
Pharmaceutical Portfolio Management Strategy
| Mar 2006 |
£2,690 |
U.S. Market for IV Therapy and Vein Access
| Jan 2006 |
£3,040 |
Health Economics in the Drug Life Cycle
Achieving success in drug discovery, development, reimbursement and marketing
| Jan 2003 |
£695 |
1
